Minerva Neurosciences Inc (NERV) is near the middle in its industry group according to InvestorsObserver. NERV gets an overall rating of 44. That means it scores higher than 44 percent of stocks. Minerva Neurosciences Inc gets a 38 rank in the Biotechnology industry. Biotechnology is number 15 out of 148 industries.
NERV has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on NERV!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Minerva Neurosciences Inc Stock Today?
Minerva Neurosciences Inc (NERV) stock is up 5% while the S&P 500 is down -0.2% as of 10:18 AM on Wednesday, Feb 28. NERV has gained $0.14 from the previous closing price of $2.80 on volume of 234,111 shares. Over the past year the S&P 500 has risen 27.63% while NERV has gained 36.11%. NERV lost -$4.61 per share the over the last 12 months.
Click Here to get the full Stock Report for Minerva Neurosciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
